logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11123324 B1

PDFFull Text
Date of Patent:
Sep. 21, 2021

Filed:

Aug. 17, 2017

Immunomodulator

Applicants:

National University Corporation Nara Institute of Science and Technology, Nara, JP;

Noster Inc., Kyoto, JP;

Inventors:

Reiko Shinkura, Nara, JP;

Kota Yamamoto, Nara, JP;

Assignees:

NOSTER INC., Kyoto, JP;

NATIONAL UNIVERSITY CORPORATION NARA INSTITUTE OF SCIENCE AND TECHNOLOGY, Nara, JP;

Attorney:

Marshall, Gerstein & Borun LLP

Primary Examiner:

Heidi Reese

Int. Cl.
CPC ...
A61K 31/365 (2006.01); A61K 31/407 (2006.01); A61P 37/08 (2006.01); A61K 45/00 (2006.01); A61P 11/06 (2006.01); A61P 27/02 (2006.01); A61P 43/00 (2006.01); A61P 17/00 (2006.01); A61P 37/02 (2006.01); A61P 17/04 (2006.01); A61P 11/02 (2006.01); A61K 39/39 (2006.01); A61P 1/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/365 (2013.01); A61K 31/407 (2013.01); A61K 39/39 (2013.01); A61K 45/00 (2013.01); A61P 1/04 (2018.01); A61P 11/02 (2018.01); A61P 11/06 (2018.01); A61P 17/00 (2018.01); A61P 17/04 (2018.01); A61P 27/02 (2018.01); A61P 37/02 (2018.01); A61P 37/08 (2018.01); A61P 43/00 (2018.01);
Abstract

The present invention provides a pharmaceutical composition to be used for the treatment or prophylaxis of allergic diseases. More specifically, the present invention provides a pharmaceutical composition to be used for the treatment or prophylaxis of allergic diseases, which contains a substance that induces selective IgA class switching in B cells. As a substance that induces selective IgA class switching in B cells, a PKC activator can be used. In addition, a composition containing a substance that induces selective IgA class switching in B cells can also be useful as a mucosal adjuvant.

Find Patent Forward Citations

Loading…